Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Anti-CD2 MAb enters phase II for GVHD

Dec. 23, 1996

Autoimmune disease Rx enters clinical trials

Dec. 20, 1996

Antex to be issued patent covering H. influenzae proteins

Dec. 19, 1996

Positive results reported for group A Streptococcus vaccine

Dec. 18, 1996

Method of producing infectious RSV offered for licensing

Dec. 17, 1996

MedImmune files IND for HPV vaccine candidate

Dec. 16, 1996

SKB reports new vaccine compositions

Dec. 16, 1996

Affymax researches potential malaria vaccines

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...